Search EdNeuro Page
The search found 21 results in 0.059 seconds.
Search results
Results of the FOCUS clinical trial led by Professor Martin Dennis and Professor Gillian Mead (Centre for Clinical Brain Sciences), which tested the efficacy of fluoxetine to improve physical ability in stroke patients indicated that there was no improvement in patients given this drug compared with patients given a placebo drug.
By- James Hogg
Prof Margaret Frame and Prof Valarie Brunton (both Centre Research UK Edinburgh Centre, Institute for Genetics & Molecular Medicine) have been awarded a £2.4 million Cancer Research UK Programme Award to understand more about brain tumours and how to target them with drugs – focusing on the most common type of brain tumour, called glioblastoma.
Many congratulations to Prof Seth Grant and colleagues who have published a mouse brain synapse atlas, from birth to old age, in the journal 'Science'.
Dr Heather Whalley and Prof Andrew McIntosh (both Centre for Clinical Brain Sciences) and colleagues from the Centre for Cognitive Ageing & Cognitive Epidemiology and the University of Glasgow have found, using diffusion tensor imaging, that white matter integrity is reduced in people with symptoms indicative of depression compared to those without.
Dr Christos Gkogkas and colleagues in the Patrick Wild Centre have found that a commonly used diabetes drug, Metformin, could help people with a common inherited form of autism (fragile X syndrome).
Huge congratulations to Dr Sarah McGlasson (UK Dementia Research Institute) who was presented wit
Congratulations to Noah Stypidou (PhD Student, Centre for Discovery Brain Sciences) on winning the best student poster prize (preregistration category) at the British Neuroscience Association Festival of Neuroscience in April.
Scientists led by Dr Tilo Kunath (MRC Centre for Regenerative Medicine) have taken a key step towards improving an emerging class of treatments for Parkinson’s disease. The advance could improve a next generation of therapies for the condition, which affects around one in 350 people in the UK.
The author J. K. Rowling has donated £15.3m to the University of Edinburgh to help improve the lives of people with multiple sclerosis (MS) and similar conditions. The investment will help create new facilities and support vital research at the University's Anne Rowling Regenerative Neurology Clinic, as well as support research projects focussing on the invisible disabilities experienced by people living with MS, such as cognitive impairment and pain.